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Abstract
Chronic wounds are a major disease burden worldwide. The breach of the epithelial 
barrier facilitates transition of skin commensals to invasive facultative pathogens. 
Therefore, we investigated the potential effects of Staphylococcus aureus (SA) on 
dermal fibroblasts as key cells for tissue repair. In co- culture systems combining live 
or heat- killed SA with dermal fibroblasts derived from the BJ- 5ta cell line, healthy 
individuals, and patients with systemic sclerosis, we assessed tissue repair including 
pro- inflammatory cytokines, matrix metalloproteases (MMPs), myofibroblast func-
tions, and host defense responses. Only live SA induced the upregulation of IL- 1β/- 
6/- 8 and MMP1/3 as co- factors of tissue degradation. Additionally, the increased 
cell death reduced collagen production, proliferation, migration, and contractility, 
prerequisite mechanisms for wound closure. Intracellular SA triggered inflammatory 
and type I IFN responses via intracellular dsDNA sensor molecules and MyD88 and 
STING signaling pathways. In conclusion, live SA affected various key tissue repair 
functions of dermal fibroblasts from different sources to a similar extent. Thus, SA 
infection of dermal fibroblasts should be taken into account for future wound man-
agement strategies.
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1 |  INTRODUCTION
Chronic wounds have become a problem of epidemic propor-
tions worldwide.1,2 Disturbed circulation due to macroangiop-
athy as in peripheral arterial occlusive disease or resulting from 
microangiopathy such as in diabetes mellitus or certain auto-
immune disorders is a major contributing factor.3 For example 
in systemic sclerosis (SSc), a multi- systemic autoimmune con-
nective tissue disease, up to two thirds of patients suffer from 
chronic digital ulcers (DU),4 which are often complicated by 
necrosis, soft tissue infection, and osteomyelitis.5 Chronic non- 
healing wounds are characterized by persistent inflammation, 
defective re- epithelialization, and impaired matrix remodel-
ing.3,6 Chronic wounds are always colonized by bacteria.1,7 In 
dermal ulcers, the breach of the basement membrane8 exposes 
dermal tissue and cells to commensal skin bacteria, facilitating 
invasion.9 Staphylococcus aureus (SA) is a common colonizer 
of the human skin and one of the most prevalent opportunistic 
pathogens in chronic wounds1,10,11 as well as a cause of serious 
local and systemic infections.12 SA produces various virulent 
factors such as α- toxin, enterotoxins, and coagulase, which 
damage cell membranes and induce cell death.13 In addition, 
cell surface molecules such as lipopeptides, peptidoglycan and 
lipoprotein can activate immune cells via pattern (=pathogen) 
recognition receptors (PRRs) resulting in an enhanced pro- 
inflammatory response, which also delays wound healing.14 
However, recent research points toward novel mechanisms 
of SA pathogenicity with respect to chronic and/or recurrent 
wound infections. While long considered a strictly extracellular 
pathogen, recent studies showed that SA survived phagocytosis 
by macrophages and neutrophils, and induced its intracellular 
uptake even in non- professional phagocytes including, for ex-
ample, epithelial and endothelial cells, osteoblasts, and murine 
fibroblasts.9,15 Intracellular SA causes cytotoxicity, but also 
may progress to persistence and then represents a mechanism 
of immune evasion leading to recurrence or chronicity of infec-
tions, and further bacterial dissemination.9,16
Dermal fibroblasts are cellular key players in physiologic 
wound healing3 since they proliferate and produce extracellu-
lar matrix proteins to fill up the wound.1 Although the diverse 
effects of SA on the immune system have been described, its 
effect on fibroblast functions in the context of dermal wound 
healing, and especially its contribution to non- healing DUs in 
SSc, has not yet been investigated. Therefore, we evaluated the 
interaction of SA and dermal fibroblasts with respect to key 
tissue repair functions including potential signaling pathways.
2 |  MATERIALS AND METHODS
2.1 | Study subjects
Human primary dermal fibroblasts were obtained from lesional 
skin of patients with diffuse cutaneous (dc) SSc (n = 3) and 
from skin biopsies from healthy controls (HC) (n = 3) as pre-
viously described.17 Wound swabs of DU were subjected to 
routine microbiology diagnostics in 30 SSc patients. The main 
characteristics of the analyzed SSc patients (n = 30) at the time 
of the microbial sampling are provided in Table  1. Written 
informed consent was obtained. The study was approved by 
the Zurich ethics committee (pre- BASEC- EK- 839, BASEC 
KEK- no. 016- 01515, BASEC- no. 2014- 0197, KEK- no. 2018- 
0187). Patients/public were not involved in the study.
2.2 | Cell culture
Human primary dermal fibroblasts were obtained from 
forearms of dcSSc patients and HCs at the department of 
Rheumatology, University Hospital Zurich. Skin was minced 
into small pieces with a sterile scalpel. The pieces were trans-
ferred to a 6- well plate with the dermis facing the bottom 
of the plate. The skin pieces were incubated with complete 
cell culture medium (DMEM containing 10% fetal calf serum 
(FCS), 50 units/mL of penicillin, 50 μg/mL of streptomycin 
and 100 μM of 2- mercaptoethanol) to let fibroblasts outgrow 
from the skin for at least two weeks. Cells were passed 3 
times to get rid of other cell types and expand the culture. The 
purity of the obtained fibroblasts was confirmed by FACS 
analysis and immunofluorescence. FACS analysis revealed 
that more than 90% of cells were CD90+CD45- CD31- . 
Immunofluorescence showed robust expression of alpha- 
smooth muscle actin and stress fiber upon TGF- beta stimu-
lation (Figure S1). These results suggested that our primary 
fibroblasts consisted of a sufficiently pure cell population.
Primary dermal fibroblasts were cultured in the complete 
cell culture medium. Human neonatal fibroblasts immortal-
ized with hTERT (BJ- 5ta, ATCC CRL- 4001) were cultured 
in DMEM and Medium 199 (mix ratio 4:1; Sigma- Aldrich, St 
Louis, MO) containing 10% FCS and 0.01 mg/mL of hygromy-
cin (Sigma- Aldrich) at 37°C in 5% carbon dioxide. Cells were 
stimulated with 1 × 105 or 1 × 107 CFU/mL of live SA (ATCC 
6538; kindly provided by A. S. Zinkernagel) or 1 × 108/mL of 
HKSA (InvivoGen, San Diego, CA), and then were used for 
each subsequent analysis. The maximum bacterial load was de-
termined by cytotoxicity assay using Cell Counting Kit- 8 (CCK- 
8; Dojindo Molecular Technologies, Rockville, MD). Treatment 
of both primary human dermal fibroblasts and BJ- 5ta cells with 
SA at a bacterial load within a range of 1 × 104- 5 × 107 was 
found to have no cytotoxic effect (>95% viability) on such cells.
2.3 | Bacterial strain and bacterial co- 
culture stimulation system
SA (ATCC 6538) was stored in Tryptic soy broth (TSB; BD 
Biosciences, San Jose, CA) medium containing 20% glycerol 
at −20°C. Bacteria were cultured in 3 mL of TSB medium in a 
   | 3 of 16YOKOTA ET AL.
10 mL Falcon round bottom tube for 18 h at 37°C in an incu-
bator shaker to reach the early stationary phase for use in the 
co- culture system. The bacterial concentration was estimated 
by measuring the optic density of bacterial suspension with an 
optical densitometer (BioRad, Hercules, CA). Bacteria were 
harvested by centrifugation at 4200 g for 10 min. The bacterial 
pellet was washed with phosphate- buffered saline (PBS) twice 
and then suspended in DMEM supplemented with 1% human 
albumin (Sigma- Aldrich) and 25  mM of HEPES (Thermo 
Fisher Scientific, Waltham, MA) (invasion medium). The 
bacteria containing medium was then added to a monolayer 
of cultured fibroblasts,16,18 plated as per assay requirements. 
Stimulation of fibroblasts was unopposed by antibiotics for 
3 h. Thereafter DMEM with 1% FCS supplemented with the 
antibiotic flucloxacillin sodium (0.1 mg/mL) (Sigma- Aldrich) 
was added. The concentration was determined by bacteria kill-
ing assay to minimize undesirable effects on fibroblasts.
2.4 | ELISA
One hundred thousand cells were cultured in a 6- well plate. 
After 24 h starvation with 1% FCS, cells were washed with 
PBS and treated with the indicated amount of SA as de-
scribed above. After 72 h incubation, the supernatants were 
collected. The levels of IL- 1β, IL- 6, IL- 8, IFN- β and pro- 
collagen Iα1 in the co- culture supernatants were quantified 
using ELISA assays (R&D Systems, Minneapolis, MN) and 
a microplate reader (Biotek Instruments, Winooski, VT) ac-
cording to the manufacturer's protocols.
2.5 | Quantitative real- time PCR 
(qPCR) analysis
Fifty thousand cells were cultured in a 12- well plate. After 
a 24 h starvation with 1% FCS, cells were washed with PBS 
and treated with the indicated amount of SA as described 
above. After 24 h incubation, cells were washed with PBS 
and total RNA samples were prepared using a Quick- RNA 
MicroPrep Kit (Zymo research, Irvine, CA). Synthesis 
of cDNA was performed using a Transcriptor First 
Strand cDNA Synthesis Kit (Roche, Basel, Switzerland). 
Quantitative PCR was performed using a Stratagene 
Mx3005P Quantative PCR System (Agilent Technologies, 
Santa Clara, CA) making use of a SYBR green reagent 
(Promega, Madison, WI). The levels of each gene were nor-
malized to the levels of RPLP0. The sequences of primers 
used are presented in Table 2.
2.6 | Migration assay
Migration assays were performed as described19 using a 2- 
well cell culture insert (Ibidi, Planegg, Germany) allowing 
for an equal gap down the center of a cellular monolayer. 
After bacterial co- culture, serial imaging of fibroblast mi-
gration was performed using an imaging system (IX81; 
Olympus, Tokyo, Japan) equipped with excellencePro soft-
ware (Olympus). Fibroblast migration was measured by 
assessing the percentage of the gap still uncovered by fibro-
blasts at various time intervals using ImageJ software (NIH, 
Bethesda, MD).
2.7 | Cell contraction assay
A collagen solution (400 μL) was prepared from the cell con-
traction assay kit (Cell Biolabs, San Diego, CA) and mixed 
with 100 μL of cell- bacteria solution. The solution was plated 
in a 24- well culture plate and incubated for 1 h to allow po-
lymerization of the collagen gel. Thereafter, 1000 μL of the 
DMEM (Sigma- Aldrich) containing 1% FCS was added to 
each well, followed by flucloxacillin after 2 h. After 48 h, the 
gel was gently released from the sides of the well and after 
further 6 h, the area of each gel was measured using ImageJ 
software.
T A B L E  1  Patients' main characteristics
Parameters Numbers
Age (years) 42 (20- 79)
Gender (m/f) 3/27 (10/90%)
Disease duration (years) 8 (0- 49)
Skin involvement
Limited cutaneous 12 (40%)
Diffuse cutaneous 15 (50%)
Only sclerodactyly 3 (10%)
Raynaud's phenomenon 30 (100%)
Presence of active digital ulcers 30 (100%)
Number of digital ulcers 3 (1- 20)
Auto- antibody status
ANA 28 (93%)
Anti- Centromere 18 (60%)
Anti Scl- 70 14 (47%)
Anti RNA- Polymerase 6 (20%)
Anti- U1nRNP 3 (10%)
Organ involvement
Pulmonary arterial hypertension 4 (13%)
Lung fibrosis (HRCT scan) 16 (53%)
Esophageal symptoms 23 (77%)
Intestinal symptoms 17 (57%)
Stomach symptoms 17 (57%)
Renal crisis 0 (0%)
Immunosuppressive therapy 10 (30%)
Note: Data are presented as absolute numbers (percentages) or medians (ranges).
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2.8 | Proliferation assay
Cells were seeded into a 96- well plate. After 24 h starva-
tion, the cells were cultured with SA as described above. 
After 72 h, cell proliferation was assessed by CCK- 8 ac-
cording to the manufacturer's protocol. The absorbance 
was then read at 450 nm using a microplate reader (Biotek 
Instruments).
2.9 | Apoptosis and necrosis assay
Cells were seeded into a white 96- well plate. After overnight 
culture, the cells were cultured with SA as described above. 
After 3 h of bacterial co- culture, apoptosis and necrosis were 
assessed at 7 h (4 h after flucloxacillin was added) using 
RealTime- Glo Annexin V Apoptosis and Necrosis Assay 
(Promega). Chemiluminescence and fluorescence were 
measured using a microplate reader.
2.10 | Invasion assay
One hundred thousand cells were cultured in a 6- well plate. 
After 24 h starvation, cells were washed twice with PBS and 
treated with the indicated amount of SA in invasion medium for 
3 h. Hereafter, the supernatant was aspirated and the cells were 
treated with lysostaphin (Sigma- Aldrich), which is an antibac-
terial endopeptidase, for 1 h to eradicate extracellular bacteria. 
Cells were washed once with PBS and then lysed with distilled 
water. The lysate containing intracellular bacteria was diluted 
and seeded on agar plates. Bacterial invasion was quantified by 
counting the number of bacterial colonies on the plates.20
2.11 | Immunofluorescence and 
confocal microscopy
Glass cover slips with a diameter of 12 mm were placed 
in 24- well plates. Thereafter, 5 × 104 fibroblasts (in 
Gene symbol Primer sequence
RPLP0 Forward primer: 5′- ACA CTG GTC TCG GAC CTG AGA A- 3′
Reverse primer: 5′- AGC TGC ACA TCA CTC AGA ATT TCA- 3′
MMP1 Forward primer: 5′- CTC TGG AGT AAT GTC ACA CCT CT- 3′
Reverse primer: 5′- TGT TGG TCC ACC TTT CAT CTT C- 3′
MMP3 Forward primer: 5′- TCA CTC ACA GAC CTG ACT CG- 3′
Reverse primer: 5′- AAA GCA GGA TCA CAG TTG GC- 3′
TLR2 Forward primer: 5′- CTG TGC TCT GTT CCT GCT GA- 3′
Reverse primer: 5′- GAT GTT CCT GCT GGG AGC TT- 3′
TLR9 Forward primer: 5′- AAT CCC TCA TAT CCC TGT CCC- 3′
Reverse primer: 5′- GTT GCC GTC CAT GAA TAG GAA G- 3′
MYD88 Forward primer: 5′- GCA CAT GGG CAC ATA CAG AC- 3′
Reverse primer: 5′- GAC ATG GTT AGG CTC CCT CA- 3′
ZBP1 Forward primer: 5′- AAC ATG CAG CTA CAA TTC CAG A- 3′
Reverse primer: 5′- AGT CTC GGT TCA CAT CTT TTG C- 3′
CGAS Forward primer: 5′- ACA TGG CGG CTA TCC TTC TCT- 3′
Reverse primer: 5′- GGG TTC TGG GTA CAT ACG TGA AA- 3′
IFI16 Forward primer: 5′- TAG AAG TGC CAG CGT AAC TCC- 3′
Reverse primer: 5′- TGA TTG TGG TCA GTC GTC CAT- 3′
TMEM173 Forward primer: 5′- CAC TTG GAT GCT TGC CCT C- 3′
Reverse primer: 5′- GCC ACG TTG AAA TTC CCT TTT T- 3′
IL1B Forward primer: 5′- ATG CAC CTG TAC GAT CAC TG- 3′
Reverse primer: 5′- ACA AAG GAC ATG GAG AAC ACC- 3′
IL6 Forward primer: 5′- CTC TTC AGA ACG AAT TGA CAA ACA A- 3′
Reverse primer: 5′- GAG ATG CCG TCG AGG ATG TAC- 3′
IL8 Forward primer: 5′- TTG GCA GCC TTC CTG ATT TC- 3′
Reverse primer: 5′- TGG CAA AAC TGC ACC TTC AC- 3′
IFNB1 Forward primer: 5′- GTC ACT GTG CCT GGA CCA TAG- 3′
Reverse primer: 5′- GTT TCG GAG GTA ACC TGT AAG TC- 3′
T A B L E  2  qPCR primer sequences
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500 µL/well) in DMEM with 1% FCS (1% FCS- DMEM) 
were added and starved for 24 h. SA cultures were grown 
overnight in 5  mL TSB and then adjusted to reach 2 × 
108 CFU/mL. Cells were infected with MOI (multiplicity 
of infection) 1 (1 × 105 CFU/mL) or 100 (1 × 107 CFU/
mL) in 1% FCS- DMEM. After 3 h of bacterial invasion, 
the supernatants were aspirated and cells were fixed with 
4% paraformaldehyde. Nucleic acids (eukaryotic nuclei 
and bacteria) were then stained with 20 µM Hoechst rea-
gent, washed once with PBS, and then blocked with PBS 
supplemented with 1% bovine serum albumin (1% BSA- 
PBS). Thereafter, 1:100 rhodamine phalloidin (Invitrogen, 
Waltham, MA) was added to stain actin. After the removal 
of the blocking buffer and the actin dye, a mouse mono-
clonal primary antibody against SA (clone 704; Abcam, 
Cambridge, MA) was added in 1% BSA- PBS at a final 
concentration of 2 µg/mL. After washing once with PBS, 
a goat anti- mouse antibody Alexa 488 (Invitrogen) was 
added in 1% BSA- PBS at a final concentration of 4 µg/mL. 
To stain late endosomes, a mouse primary antibody against 
LAMP2 (BD Biosciences) and a goat anti- mouse antibody 
Alexa 488 (Invitrogen) were used. For identification of 
intracellular SA in Figure  3, CFSE (carboxyfluorescein 
succinimidyl ester)- labeled SA or HKSA were used. After 
washing once with PBS, cells were mounted in ProLong 
Gold (Invitrogen) on glass slides. Images were obtained 
with an inverted SP8 confocal laser scanning microscope 
(Leica, Wetzlar, Germany).
2.12 | Blockade of endocytosis
Cells were treated with 10 µg/mL of cytochalasin D (Sigma- 
Aldrich) for 1 h. After the cells were washed with PBS, bac-
teria containing medium were added to the wells to examine 
the effect of bacterial invasion on cell death or expression of 
IFN- β and inflammatory mediators.
2.13 | Gene knockdown by siRNA
Human MYD88 siRNA, human TMEM173 siRNA, and 
AllStars Negative Control siRNA were purchased from 
Qiagen (Venlo, Netherlands). The sequences of the siRNAs 
are shown in Table 3 below.
Fifty thousand cells were cultured without antibiot-
ics in a 12- well plate. After overnight culture, siRNA- 
Lipofectamine2000 (Thermo Fisher Scientific) complexes 
in Opti- MEM I Reduced Serum Medium (Thermo Fisher 
Scientific) were prepared for each transfection sample. The 
siRNA- Lipofectamine complexes were added to each well, 
and the cells were incubated in a humidified CO2 incubator. 
The final concentration of each siRNA was 20 nM. After 6 
h incubation, the cell culture medium was changed to fresh 
DMEM with 1% FCS. After further 18 h incubation, the cells 
were used for each gene knockdown assay.
2.14 | Statistical analysis
Data are summarized as medians or means depending on the 
experimental setting. The statistical analysis was performed 
using Prism 8.1 (GraphPad Software, San Diego, CA). The 
respective statistical analyses are specified in each figure leg-
end. P values <.05 were considered significant.
2.15 | FACS analysis
Cells were co- cultured with the indicated amount of SA for 
24, 48, or 72 h. Cells were treated with 2 μM of monensin 
(Sigma- Aldrich) for the final 6  h. Cells were washed and 
incubated with LIVE/DEAD Fixable Near- IR Dead Cell 
Stain (Thermo Fisher Scientific) for 30 min. Thereafter, anti- 
CD45- eFluor 450 (clone HI30), anti- CD31- Super Bright 600 
(clone WM- 59) (Thermo- Fischer Scientific), and anti- CD90- 
APC (clone 5E10; BD Biosciences) antibody for 30  min 
at 4°C. Cells were then fixed with Cytofix/Cytoperm Cell 
Permeabilization/Fixation Solution (BD) for 15 min at 4°C. 
Cells were then washed and incubated with anti- IL- 6- PE 
(clone MQ2- 6A3, BD), anti- IL- 8- PE (Clone 8CH, Thermo 
Fisher) or anti- IFN- β- Fluorescein (Clone MMHB- 3, R&D 
Systems) for 30 min at 4°C. Purity of primary fibroblasts and 
level of intracellular cytokine expression were analyzed on a 
flow cytometer (Attune NxT, Thermo Fisher). Flow cytom-
etry data were analyzed with FlowJo (v10.2, BD).
siRNA Sequence
TMEM173 Target Sequence: 5′- CCG CAC GGA TTT CTC TTG AGA- 3′
Sense strand: 5′- GCA CGG AUU UCU CUU GAG ATT- 3′
Antisense strand: 5′- UCU CAA GAG AAA UCC GUG CGG- 3′
MYD88 Target Sequence: 5′- CAG GAC CAG CTG AGA CTA AGA- 3′
Sense strand: 5′- GGA CCA GCU GAG ACU AAG ATT- 3′
Antisense strand: 5′- UCU UAG UCU CAG CUG GUC CTG- 3′
T A B L E  3  siRNA sequences for 
TME173 and MYD88
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2.16 | Immunofluorescence of human 
primary dermal fibroblasts
Cells were cultured on an 8- well chamber slide (Thermo 
Scientific) with 10 ng/mL of TGF- β1 for 72 h. Cells were then 
washed and fixed with 4% paraformaldehyde for 5 min. Cells 
were permeabilized with 0.1% Triton X- 100 (Sigma- Aldrich) 
for 5 min. After blocking with 10% FCS for 20  min, cells 
were incubated with anti- actin, α- smooth muscle (clone 1A4; 
Sigma- Aldrich) for 1 h at room temperature. Cells were then 
washed and incubated with anti- mouse IgG- Alexa Flour 488 
(Thermo Fischer Scientific) and phalloidin- TRITC (Sigma- 
Aldrich) for 45 min. Nucleic acids were then stained with DAPI 
(4′,6- diamidino- 2- phenylindole; Roche). After washing with 
PBS, cells were mounted in fluorescence mounting medium 
(Dako) and images were obtained with a fluorescence micro-
scope (DP80, Olympus).
2.17 | Cell count
Fifty thousand cells were co- cultured with the indicated 
amount of SA for 24, 48, or 72 h on 12- well plates. Cells were 
stained with trypan blue. Live and dead cells were then de-
termined using an automated cell counter (TC10, Bio- Rad).
3 |  RESULTS
3.1 | Chronic DU of SSc patients are 
colonized by SA
To assess which bacteria are predominantly found in chronic 
DU, we analyzed wound swabs of 30 SSc patients from our 
department. Most patients with DU showed positive results 
with mostly moderate (CFU = 104- 105/mL, ie, critically col-
onized; 30%) or plentiful bacterial growth (CFU >105- 106/
mL, ie, infected; 37%), while only 5 (17%) did not show any 
growth at all. In 53% of dermal wounds, SA was detected. 
Other detected bacterial strains included Pseudomonas 
aeruginosa, Haemophilus parainfluenzae, Enterobacter 
cloacae, Enterococcus faecalis, Streptococcus pyogenes, 
Klebsiella pneumoniae, Proteus vulgaris, Staphylococcus 
lugdunensis, and Staphylococcus epidermidis. In SA- positive 
wounds, deep soft tissue infections (n = 7, 43.8%) and osteo-
myelitis (n = 5, 31.3%) occurred more often. These findings 
are in accordance with previous reports.10,11
3.2 | SA affects key functions of dermal 
fibroblasts
To investigate the impact of SA- fibroblast interactions on 
tissue repair we first co- cultured dermal fibroblasts (BJ- 5ta) 
with live SA. We deliberately chose a cell line for the first 
evaluation step in order to avoid the potential heterogeneity 
of results that might arise from the use of primary cells. A 
lower inoculum representing colonization (1 × 105 CFU/mL) 
and a higher inoculum reflecting infection (1 × 107 CFU/mL) 
were used.21 We confirmed dose- dependent effects of SA 
between 1 × 105 and 1 × 107 CFU/mL on some fibroblast 
functions (Figure S2).
Exposure to the higher inoculum influenced several im-
portant fibroblast functions. The secretion of IL- 6 and IL- 8 
by dermal fibroblasts was increased to 1340 pg/mL (P < .05) 
and to 120 pg/mL (P = .12), respectively (Figure 1A). IL- 1β 
was not detected by ELISA (data not shown) at 72 h. The gene 
expression was likewise upregulated for IL- 6/- 8 (Figure 1B). 
Although the gene expression of IL- 1β was also upregulated 
(Figure 1B), the expression level relative to ribosomal protein 
lateral stalk subunit P0 (RPLP0) was much lower than those 
of IL6 and IL8 (data not shown) consisting with no detection 
of IL- 1β protein. The increased secretion and gene expression 
of the cytokines were already observed at 24 h (Figure S3). 
In addition, we observed an upregulated gene expression of 
MMP1 by 2.8- fold (P < .05) and MMP3 by 1.9- fold (P < .05) 
(Figure 1C). Wound closure as assessed by migration was re-
duced by 34% at 16 h (P = .64) (Figure 1D). Type 1 collagen 
synthesis was significantly decreased in 1 × 107 CFU/mL of 
SA- challenged BJ- 5ta cells (Figure  1E). Collagen gel con-
traction as measure of fibroblast contractility was impaired 
by 26% (P = .05) (Figure 1F). Proliferation was reduced by 
57% (P = .26) (Figure 1G). Live cell numbers and propor-
tions of live cells at 24 h and 72 h were also assessed. Live 
cells were decreased to around 50% compared with controls 
without SA- exposure at 72 h (Figure S4). Given that the cell 
number was reduced by exposure to higher dosages of SA, we 
performed intracellular cytokine staining to assess the pro-
duction of cytokines while controlling for the cell number. 
The FACS analyses revealed that the higher dosages of SA 
increased the production of the cytokines by human dermal 
fibroblast at the single cell level (Figure S5).
To confirm the effects observed in BJ5- ta cells, we 
next assessed tissue repair mechanisms in primary cells. 
Fibroblasts from HC and dcSSc patients were co- cultured 
with live SA. As previously observed for the BJ- 5ta cells, 
only exposure to the higher inoculum influenced several im-
portant fibroblast functions. The secretion of IL- 6 and IL- 8 
by dermal fibroblasts was increased to 10 730/30 000 pg/
mL (HC/dcSSc; P < .05 each) and to 20 340/38 170 pg/
mL (HC/dcSSc; P < .05 each), respectively (Figure 1A). 
IL- 1β was not detected by ELISA (data not shown). The 
gene expression was likewise upregulated for IL- 6/- 8/- 1β 
(Figure  1B). Compared with the BJ- 5ta cell line, these 
effects were more pronounced. This was also true for the 
upregulation of MMP1 and MMP3 mRNA (Figure  1C). 
The gene expression of MMP1 was increased by 9.3/6.2- 
fold (HC/dcSSc; P = .07/= .12) and MMP3 by 3.4/5.1- fold 
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F I G U R E  1  S aureus (SA) affects key functions of dermal fibroblasts. A, The concentration of IL- 6 and IL- 8 in the culture supernatants was 
quantified at 72 h by ELISA. B, The gene expression of IL- 6, IL- 8, and IL- 1B was assessed at 72 h by qPCR analysis. C, MMP1 and MMP3 
mRNA levels were evaluated at 24 h by qPCR analysis. D, Migration assay was performed at 16 h (BJ- 5ta cells) or 28 h (primary cells). E, Pro- 
collagen 1α concentration in the culture supernatants was quantified at 72 h by ELISA. F, Cell contractility was evaluated at 48 h by collagen gel 
contraction assay. G, Cell proliferation was evaluated at 72 h using CCK- 8. H, TLR2 mRNA levels were measured by qPCR at 24 h. Bars show 
medians, n = 3 per group. *P < .05, **P < .01 (Kruskal- Wallis test followed by Dunn's multiple comparisons test)
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(HC/dcSSc; P = .16 each) (Figure 1C). Wound closure as 
assessed by migration was reduced by 12/11% at 28 h (HC/
dcSSc; P = .23/= .24) (Figure 1D). There was a trend to-
ward a decreased secretion of pro- collagen Iα (Figure 1E). 
Collagen gel contraction as a measure of fibroblast con-
tractility was impaired by 20/36% (HC/dcSSc; P  < .05 
each) (Figure 1F). Proliferation was reduced by 0.65/0.60- 
fold (HC/dcSSc; P = .91/= .26) (Figure 1G). The observed 
effects for cell migration, contraction, and cell proliferation 
were similar compared to these in BJ- 5ta cells. Overall, 
these results suggest that various fibroblast effector func-
tions are affected by SA, with potential implications for 
wound healing.
3.3 | Effects of heat- killed SA on fibroblast 
functions are less pronounced as compared to 
live SA
Cell wall components of SA can exert pro- inflammatory ef-
fects via Toll- like receptor (TLR) 2- mediated innate immune 
responses.22 Therefore, we assessed whether not only live 
SA, but also heat- killed SA (HKSA) affected mechanisms of 
tissue repair in dermal fibroblasts. TLR2 was constitutively 
expressed in dermal fibroblasts. Expression was not further 
upregulated upon SA exposure (Figure 1H). The secretion and 
the mRNA upregulation of IL- 6, IL- 8, IL- 1β (Figure 1A,B) 
and the upregulation of MMP1/3 mRNA (Figure 1C) upon 
HKSA stimulation were much lower than upon live SA ex-
posure. HKSA had no significant negative effects on migra-
tion, type 1 collagen synthesis, contractility, or proliferation 
(Figure 1D- G). These results suggest that only live SA has 
an effect on the assessed tissue repair mechanisms. Again, 
no differences were observed for fibroblasts from different 
sources.
3.4 | SA induces cell death in dermal 
fibroblasts and invades dermal fibroblasts by 
endocytosis
As live SA has been shown to induce cell death in other 
cell types,15 we examined whether this also applied to der-
mal fibroblasts. Using a real time assay, we found that SA 
increased both apoptosis by 10.9- fold (BJ- 5ta; P  < .05) 
(Figure  2A) and necrosis by 4.2- fold (BJ- 5ta; P  < .05) 
(Figure  2B). This was again confirmed in primary cells, 
where apoptosis was increased by 5.2/5.4- fold (HC/dcSSc; 
P < .05/.14) (Figure 2A) and necrosis by 9.5/10.2- fold (HC/
dcSSc; P < .05 each) (Figure 2B). The occurrence of cell 
death was time- dependent. High dosages of SA induced ap-
optosis and necrosis at earlier time points than at 24 h and 
72 h (Figure S6A,B).
Based on recent studies suggesting intracellular uptake 
and prolonged persistence of SA in non- professional phago-
cytes,9,16,23,24 we next investigated whether this applied to 
human dermal fibroblasts by assessing the colony- forming 
unit (CFU) recovery rate.20 We confirmed that lysostaphin, 
which was used to eradicate extracellular bacteria, suffi-
ciently worked by confocal microscopic analysis (Figure 3B). 
Already at the lower inoculum representing colonizing condi-
tions, but to a much larger extent at the higher inoculum mim-
icking infection, up to 60% of inoculated SA invaded primary 
dermal fibroblasts. Both HC and dcSSc fibroblasts showed a 
trend toward a higher intracellular uptake of SA as compared 
to BJ- 5ta cells (Figure 2C). This is in line with the observed 
higher levels of IL- 6/IL- 8 secretion and the mRNA upregu-
lation of IL6, IL8, IL1B, MMP1, and MMP3 in both HC and 
dcSSc fibroblasts upon co- culture with live SA (Figure 1). 
The invasion of dermal fibroblasts was further confirmed by 
confocal microscopy. Intracellular SA was detected in the 
BJ- 5ta cell line and both primary HC and SSc fibroblasts 
(Figure 2D). In contrast, HKSA was rarely detected in BJ- 5ta 
cells (Figure 3B). The images of HC and dcSSc fibroblasts 
are shown in Figures S7 and S8, respectively.
In non- professional phagocytes, adhesin- mediated en-
docytosis has been suggested as a potential mechanism for 
the intracellular uptake.25- 27 Intra- endosomal bacteria can be 
detected by co- staining with Lamp- 2.28 Using confocal mi-
croscopy, we detected CFSE- labeled SA co- stained with the 
endosomes of dermal fibroblasts (Figure 3A). We next ex-
amined whether SA invasion affected cell death using an en-
docytosis inhibitor, cytochalasin D. Cytochalasin D inhibited 
the internalization of bacteria (Figure 3B). The inhibition of 
endocytosis increased the rate of cell death in dermal fibro-
blasts (Figure  3C,D) suggesting that extracellular cytolytic 
toxins of SA rather than host cell death due to internalization 
and phagosomal escape drive cell death in infected dermal 
fibroblasts.13,15
3.5 | Intracellular SA activates both host 
defense and immune evasion responses via 
dsDNA sensors involving MyD88 and STING 
signaling pathways
Next, we evaluated whether the presence of intracellular 
SA could activate pathways explaining the observed ef-
fects on dermal fibroblasts upon co- culture with SA. In 
non- professional phagocytes, intracellular bacteria are ei-
ther inactivated by lysosomal proteases or by autophagy 
with subsequent release of bacterial DNA into the cytosol, 
where it is recognized by cytosolic pattern recognition re-
ceptors.9,29,30 These include TLR8/9,31,32 nucleotide oli-
gomerization domain (NOD) 2,33 the NOD- like receptor 3 
(NLRP3),34 and absent in melanoma 2 (AIM2),35 some of 
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F I G U R E  2  SA induces cell death in dermal fibroblasts and invades dermal fibroblasts. Apoptosis (A) and necrosis (B) were assessed at 7 
h. Bars show medians, n = 3 per group. *P < .05 (Kruskal- Wallis test followed by Dunn's multiple comparisons test). C, SA invasion of dermal 
fibroblasts. Bars show medians, n = 3 per group. The Kruskal- Wallis test followed by Dunn's multiple comparisons test was performed within each 
SA load. D, Representative pictures of intracellular (arrow heads; blue) and extracellular (arrows; magenta) SA are shown. Scale bar = 5 µm
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F I G U R E  3  SA invades dermal fibroblasts by endocytosis, but the invasion does not promote cell death. A, Representative pictures of 
intra- endosomal SA (arrow heads) in BJ- 5ta cells are shown. SA was labeled with CFSE. Scale bar = 5 µm. B, Effect of cytochalasin D on 
SA internalization, effect of lysostaphin treatment on removal of SA, and internalization of HKSA were assessed respectively in BJ- 5ta cells. 
Intracellular (arrow heads) and extracellular (arrows) are shown. SA and HKSA were labeled with CFSE. Scale bar = 10 µm. C and D, BJ- 5ta cells 
were treated with an endocytosis inhibitor, cytochalasin D (10 µg/mL) for 1 h before SA exposure. Apoptosis (C) and necrosis (D) were evaluated 
at 7 h. Bars show means, n = 4 per group. **P < .01, ****P < .0001 (Two- way ANOVA followed by Sidak's multiple comparisons test)
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which converge on the adaptor protein, myeloid differentia-
tion factor 88 (MyD88), which plays an important role in 
the host defense against SA with induction of IL- 1β, IL- 6, 
and IL- 8. On the other hand, SA can also induce a type 
I IFN response, which has been associated with immune 
evasion and involves MyD88 signaling via its downstream 
targets IRF5 and IRF7 (interferon regulatory factors).36 
Recent data on SA- mediated intracellular signaling in 
monocytes identified the adaptor protein, stimulator of in-
terferon genes (STING), as a central part of the type I IFN 
response via activation of TANK- binding kinase 1 (TBK1) 
and IRF3.37 However, the STING- TBK1 axis can also in-
duce NF- κB signaling with production of inflammatory cy-
tokines including IL- 6 and TNF- α.38
Because we found bacterial DNA in the endosomes of 
dermal fibroblasts as well as in the cytoplasm (Figures 2D 
and 3A), we hypothesized that MyD88 and STING might be 
centrally involved in the regulation of fibroblast functions 
by SA via intracellular DNA sensor molecules. The TLR9 
gene, an endosomal/lysosomal DNA sensor, was constitu-
tively expressed in dermal fibroblasts, yet not substantially 
upregulated upon SA exposure (Figure 4A). In contrast, its 
downstream target, MyD88 became significantly upreg-
ulated on mRNA level (Figure  4A). The same applied to 
the gene of STING, TMEM173, and its upstream cytoso-
lic dsDNA sensor molecules DAI/ZBP1 (DNA- dependent 
activator of IFN- regulatory factors/ Z- DNA binding pro-
tein 1), cGAS (cyclic GMP- AMP synthase), and IFI16 
(IFN gamma- inducible protein 16) in infectious conditions 
(Figure 4B).
As downstream target of both MyD88 and STING, and as 
a key factor of SA for evasion of host defense, we analyzed 
the induction of IFN- β upon SA exposure on mRNA and pro-
tein level (Figure 4C). Indeed, live SA increased IFN- β secre-
tion in dermal fibroblasts under infectious conditions up to 
24/34/35 pg/mL (BJ- 5ta/HC/dcSSc; P < .05 each). Of note, 
in contrast to live SA, HKSA had neither a relevant effect on 
the expression of intracellular DNA sensor genes (Figure 4D) 
nor on the secretion of IFN- β (Figure 4E).
To confirm the importance of STING and MyD88 for the 
induction of both the immune evasion response (type I IFN) 
and the host defense response (IL- 6, IL- 8, IL- 1β), we per-
formed knockdown experiments with small interfering RNA 
(siRNA). TMEM173 siRNA and MYD88 siRNA decreased 
the expression of their respective target genes (Figure 5A). 
Knockdown of STING or MyD88 reduced the induction of 
IFN- β (down to 68/66%; P = .07/.06), IL- 6 (down to 57/55%; 
P < .01/<.001), IL- 8 (down to 45/36%; P < .001, each), and 
IL- 1β (down to 79/66%; P < .01/<.001) (Figure 5B).
Endocytosis blockade with cytochalasin D hindering entry 
of SA into the cells largely decreased the expression of IFN- β 
(down to 26%; P < .0001), IL- 6 (down to 32%; P < .05) and 
IL- 8 (down to 28%; P < .05), but not IL- 1β (Figure 5C).
Taken together, these results suggest that the activation of 
STING and MyD88 pathways is crucial for the induction of 
IFN- β, IL- 6, IL- 8, and IL- 1β, following the invasion of fibro-
blasts by live SA (Figure 6).
4 |  DISCUSSION
Our study showed that infection of dermal fibroblasts with 
live SA induces inflammation and tissue destruction by 
impairing fibroblast functions. Results from the BJ- 5ta fi-
broblast cell line were confirmed with primary cells from 
healthy individuals and dcSSc patients. No significant dif-
ferences regarding the net effects on tissue repair functions 
between these dermal fibroblasts from different sources were 
observed in vitro.
Chronicity, recurrence, and antibiotic resistance of 
(wound) infections is a major concern worldwide.1,39,40 
Herein, we provide novel evidence for SA- induced immune 
evasion responses by dermal fibroblasts with profound poten-
tial impact for non- healing wounds. Infection is a contribut-
ing factor in both the development and persistence of chronic 
wounds. Bacterial colonization occurs in all wounds although 
the microbial burden varies.1,7 Acute immune responses upon 
tissue injury could prevent the development of bacterial infec-
tion.7 However, prolonged inflammation may impair tissue 
repair processes.3 The skin acts as a physical barrier against 
invading pathogens. If the basement membrane is breached, 
dermal tissue and cells are exposed to commensal skin bac-
teria.9 Fibroblasts are not only important for sustaining the 
tissue and organ architecture. As shown in our study, they 
also produce chemokines such asIL- 8 and MCP- 1 as well as 
IL- 6 to recruit neutrophils, macrophages, and lymphocytes 
thereby supporting these immune cells to reduce the bacterial 
burden.41 Thus, fibroblasts initiate inflammation as sentinel 
cells upon tissue injury and/or local infection.41,42 We showed 
that in the SA co- culture setting, human primary dermal fi-
broblasts also acted as non- professional phagocytes resulting 
in the intracellular uptake of up to 60% of bacteria, which was 
at least partially mediated by endocytosis as demonstrated 
by the blocking experiments with cytochalasin D. In non- 
professional phagocytes, the interaction of fibronectin (Fn), 
SA Fn- binding proteins, and integrins was shown to be a key 
element of SA- induced endocytosis.27
The opportunistic pathogen, SA escapes not only the 
host immune defense, but also anti- infective therapy in non- 
professional phagocytes.23 The post- invasion effects vary 
depending on the cell type, but prolonged “hibernation” 
periods have been shown in osteoblasts, epithelial/endothe-
lial cells and murine fibroblasts.15 Interestingly, another im-
mune evasion reaction, that is the induction of a type I IFN 
response, was mainly mediated by intracellular SA. Herein, 
we provided some evidence that a variety of intracellular 
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F I G U R E  4  Gene expression of intracellular dsDNA sensors and their downstream mediators are upregulated upon SA exposure. A, The gene 
expression of TLR9 and its downstream mediator, MyD88 was evaluated at 24 h by qPCR analysis. B, The gene expression of STING (encoded 
by TMEM173) and its upstream DNA sensing molecules was evaluated at 24 h by qPCR analysis. C, IFN- β secretion was evaluated at 72 h by 
ELISA. The expression of IFN- β gene was evaluated at 24 h by qPCR. Bars show medians, n = 3 per group. *P < .05, **P < .01 (Kruskal- Wallis 
test followed by Dunn's multiple comparisons test). D and E, Human dermal fibroblasts were cultured with HKSA. D, The gene expression of 
intracellular DNA sensor genes was evaluated at 24 h by qPCR analysis. E, IFN- β secretion was evaluated at 72 h by ELISA. Bars show medians, 
n = 3 per group. The Wilcoxon- Mann- Whitney test was performed
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(bacterial) dsDNA sensor molecules, converging either on 
MyD88 or STING signaling pathways, might be involved in 
eliciting type I IFN responses, but also (NF- κB- mediated) 
pro- inflammatory cytokine release in dermal fibroblasts. The 
TLR9- MyD88 signaling pathway was thought to be key for 
the type I IFN production by bacterial dsDNA.31 However, 
recent studies additionally identified STING as a major 
player in TLR- independent intracellular DNA sensing. A re-
cent study provided evidence that in murine bone marrow- 
derived macrophages and the human macrophage cell line, 
THP- 1, SA activated either STING (live SA) or TLR (dead 
SA) signaling pathways.37 In our experiments using dermal 
fibroblasts, in contrast to live SA, HKSA had only negligi-
ble effects on both pathways and their downstream cytokines 
suggesting that TLR2 is not involved in these responses. The 
internalization of HKSA was much less pronounced than 
that of live SA as assessed by confocal microscopic analyses 
(Figure 3B, Figures S7 and S8). Given that bacterial inter-
nalization was important for the robust expression of IL- 6, 
IL- 8, and IFN- β upon live SA exposure (Figure  5C), the 
reduced internalization of HKSA could be one of the rea-
sons why HKSA did not induced inflammatory responses. 
Another possible reason is vita- PAMPs, through which the 
innate immune system can differentiate between live and 
dead microorganisms.43 Cyclic- di- adenosine monophosphate 
(c- di- AMP) has been identified as one of the vita- PAMPs, 
which is a second messenger produced by Gram- positive bac-
teria.44 c- di- AMP is known as a STING agonist.45 Therefore, 
it is suggested that only live SA but not HKSA could induce 
IL- 6, IL- 8, and IFN- β through internalization and subsequent 
F I G U R E  5  STING and MyD88 are crucial for the induction of IFN- β and pro- inflammatory mediators upon SA exposure. A, To present 
the efficacy of gene knockdown by siRNA, the gene expression data of TMEM173 and MYD88 in the samples are shown. B, BJ- 5ta cells were 
treated with the indicated siRNA or negative control siRNA and then were co- cultured with SA. The gene expression of IFN- β, IL- 6, IL- 8, and 
IL- 1β was evaluated at 24 h by qPCR analysis. C, BJ- 5ta cells were treated with an endocytosis inhibitor, cytochalasin D (10 µg/mL) for 1 h 
before SA exposure and then were co- cultured with SA. The gene expression of IFN- β, IL- 6, and IL- 8, and IL- 1β was evaluated at 24 h by qPCR 
analysis. Bars show means, n = 3 per group. *P < .05, **P < .01, ***P < .001, ****P < .0001 (Two- way ANOVA followed by Sidak's multiple 
comparisons test)
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activation of STING- pathway. Although in our experiments, 
bacterial invasion and dsDNA sensing seemed to relay the 
major effects, we cannot exclude that to some extent host 
dsDNA upon cell death of fibroblasts might have contributed 
to the activation of the STING pathway.9
In this proof of concept study, we intentionally made use 
of a “simplified” 2D cell culture system to be able to (a) iden-
tify SA- induced fibroblast responses with relevance for wound 
healing processes and (b) start to delineate involved signaling 
pathways. Although this in vitro 2D setting does not cover the 
real- life complexity of cell- cell- and cell- matrix interactions 
occurring in human dermal tissue repair, nor do most available 
animal models. Rodent models do not mirror the human situa-
tion of wound repair due to substantial differences in skin anat-
omy and (patho- ) physiology.46 Thus, ultimately, the use of a 
human 3D skin equivalent3 for wound healing studies might 
be warranted to (a) further confirm our results and (b) allow to 
test therapeutic options with good transferability.
In conclusion, our study suggests that SA- induced alter-
ations of dermal fibroblast responses might contribute to the 
chronicity and recurrence of dermal wounds. Although fur-
ther studies are required, our results are in line with previous 
studies suggesting that targeting intracellular DNA sensing 
pathways47 could represent a novel therapeutic approach 
for (SA- infected) non- healing wounds, which are being 
increasingly recognized as a health concern of epidemic 
proportions.2
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